# Trade Mark Journal No.2026/002 9 January 2026

## WO0000001890785 (5)

Office of origin: United States of America

Date of International Registration:18 November 2025
Date of designation in the UK: 18 November 2025

International priority date claimed: 20 May 2025 (United States of America) (99194426)

Class 5
  Pharmaceutical preparations, namely, antivirals.

Atea Pharmaceuticals, Inc.

Representative: Kilpatrick Townsend & Stockton LLP, 1100 Peachtree Street, , Suite 2800, Atlanta GA 30309, UNITED STATES OF AMERICA